IN-DATE
1616MS: Bard Mission Disposable Core Biopsy Instrument 16G x 16cm
Sign in to add this product to your favorites!
| Price: | $175.00 per box of 5 |
|---|---|
| Quantity: | |
| In Stock: | 1 box of 5 |
| Expiration: | 07-2026 |
Additional Details
Bard Mission Disposable Core Biopsy Instrument
Perform your next mission with the simplicity of semi-automatic firing, the security of visual indicators and the speed that comes from excellent ultrasound visibility and consistent sample delivery. All with the Bard® Mission® Disposable Core Biopsy Instrument.
- Lightweight compact instrument is designed to easily fit in the CT gantry
- Unique ergonomic grip design provides multiple ways to use the device
- Penetration depth indicator displays the primed penetration depth
- Visual Fire Ready Indicator confirms the sample notch is fully advanced
- 10mm Adapter attaches to coaxial cannula for accurate biopsy needle positioning when primed to the 10mm penetration depth
AccessGUDID Info
- FDA Product Code: KNW
- FDA Product Code Name: INSTRUMENT, BIOPSY
- GMDN Term Code: 58990
- GMDN Term Name: Side-notch biopsy gun handpiece/needle
- GMDN Term Description: A hand-operated, non-electronic, surgical instrument designed for the automatic extraction of a small tissue sample from an anatomical structure (a biopsy), while causing minimal surrounding tissue damage, for tissue pathological examination/testing. It consists of both: 1) a handpiece with a spring-loaded mechanism and release trigger; and 2) a percutaneous, distal, needle-like portion with a side-notch cutter which when activated causes a sharp, sliding cannula to slice a segment of tissue. It is typically used to obtain samples of soft tissue from the kidneys, prostate, pancreas, liver, and breast, often performed under image guidance. This is a single-use device.
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.
